chitosan has been researched along with n 0437, (-)-isomer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alhakamy, NA; Anwer, MK; Bhattamisra, SK; Choudhury, H; Lim, WM; Md, S; Radhakrishnan, AK; Safian, NH; Shahzad, N; Shak, AT; Xi, LW | 1 |
| Pandey, MM; Saha, P | 1 |
| Alruwaili, NK; Awad Alsaidan, O; Muqtader Ahmed, M; Saad Alharbi, K; Sarim Imam, S; Singh, L; Yasir, M; Zafar, A | 1 |
3 other study(ies) available for chitosan and n 0437, (-)-isomer
| Article | Year |
|---|---|
Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson's disease.
Topics: Administration, Intranasal; alpha-Synuclein; Animals; Blood-Brain Barrier; Cell Line, Tumor; Chitosan; Disease Models, Animal; Dopamine Agonists; Drug Carriers; Female; Haloperidol; Humans; Male; Nanoparticles; Neurons; Oxidopamine; Parkinson Disease, Secondary; Particle Size; Rats; Tetrahydronaphthalenes; Thiophenes; Toxicity Tests, Acute | 2020 |
A new fluorescence-based method for rapid and specific quantification of rotigotine in chitosan nanoparticles.
Topics: Chitosan; Humans; Nanoparticles; Tetrahydronaphthalenes; Thiophenes; United States | 2022 |
Formulation of intranasal surface engineered nanostructured lipid carriers of rotigotine: Full factorial design optimization, in vitro characterization, and pharmacokinetic evaluation.
Topics: Administration, Intranasal; Animals; Chitosan; Drug Carriers; Lipids; Nanostructures; Particle Size; Rats; Rats, Wistar | 2022 |